These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12546108)

  • 1. What to do until HAART arrives?
    Murray JF
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1035-7. PubMed ID: 12546108
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-HIV agents. Some American women don't reap a large benefit from HAART.
    TreatmentUpdate; 2004 Jan; 16(1):4-6. PubMed ID: 17219663
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotics and HIV. Healing infection without hindering HAART.
    Briggs JM; Narsavage GL
    Adv Nurse Pract; 2004 Jul; 12(7):26-34; quiz 35. PubMed ID: 15315057
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral therapy in HIV.
    Yu A; Berbari E; Temesgen Z
    J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004.
    Donoghoe MC; Bollerup AR; Lazarus JV; Nielsen S; Matic S
    Int J Drug Policy; 2007 Aug; 18(4):271-80. PubMed ID: 17689375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAART--the need for strategically focused investments.
    Feachem R
    Bull World Health Organ; 2001; 79(12):1152-3. PubMed ID: 11842786
    [No Abstract]   [Full Text] [Related]  

  • 7. Universal access to antiretroviral therapy: when, not if.
    Carpenter CC
    Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
    [No Abstract]   [Full Text] [Related]  

  • 8. Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
    Flanigan TP; Wools-Kaloustain K; Harwell J; Cu-Uvin S; Kimaiyo S; Carter EJ
    Clin Infect Dis; 2007 Dec; 45(11):1499-501. PubMed ID: 17990234
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid scaling-up of access to antiretroviral therapy in Mexico: Is it better not to treat?
    Volkow P; Villasis A; Cornejo P; Sierra-Madero J
    AIDS; 2007 Jan; 21(2):261-2. PubMed ID: 17197827
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple tuberculous brain abscesses in an HIV-infected patient successfully treated with HAART and antituberculous treatment.
    Bottieau E; Noë A; Florence E; Colebunders R
    Infection; 2003 Mar; 31(2):118-20. PubMed ID: 12682819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant growth in access to HIV treatment in 2006.
    Saudi Med J; 2007 Nov; 28(11):1767-70. PubMed ID: 18213927
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

  • 13. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.
    Torres MA
    Chic J Int Law; 2002; 3(1):105-14. PubMed ID: 15709302
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to HIV drugs: are we changing the two world paradigm?
    Lazzarini Z
    Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan.
    Fang CT; Hsu HM; Twu SJ; Chen MY; Chang YY; Hwang JS; Wang JD; Chuang CY;
    J Infect Dis; 2004 Sep; 190(5):879-85. PubMed ID: 15295691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.